PubMed Central and F1000 Research — More Signs of Favoritism and Activism, and More Conflicts of Interest
More indications of favoritism and cronyism, this time stretching back from F1000 Research to BioMed Central, and more mismanaged conflicts of interests. The common thread may be a new “old boys” network.